December 2014, Vol 3, No 8

Reflections on 2014 – Enthusiasm for 2015

Dear Colleague, What an incredible year for the oncology community. We have witnessed great strides in our ability to fight cancer, most notably with immunotherapeutics. As a result, we have glimpsed a possible future of cancer care that will cater to the individual patient, making personalized medicine a reality, and [ Read More ]

Al B. Benson III, MD, FACP, FASCO

Letter to Our Readers

Providing Therapeutic Guidance for Breast Cancer Patients in the Molecular Era With the Breast Cancer Index(SM) Assay:

An Interview with Stephen C. Malamud, MD, and Susan K. Boolbol, MD, of Mount Sinai Beth Israel Hospital

With the advent of gene expression profiling, we have gained the ability to objectively advise patients with breast cancer, among other cancers, on their risk of recurrence and potential benefit of therapies through the administration of assays designed to provide predictive and prognostic data. This is welcome news for a [ Read More ]

Susan K. Boolbol, MD

Interview with the Innovators

Putting the “Person” in Personalized Cancer Medicine: A Systematic Review of Psychological Aspects of Targeted Therapy

Targeted therapies in the new era of molecular medicine are currently used in most oncologic settings with increasing success. They have hit the prime time and are the star agents for many oncologic diseases. Yet, they add an additional layer of complexity to cancer care. They represent a paradigmatic shift [ Read More ]

Daniel C. McFarland, DO

Psychosocial Oncology

World Cutaneous Malignancies Congress

The Third Annual World Cutaneous Malignancies Congress (WCMC) took place in San Francisco, California, on October 29-31, 2014. The WCMC is a 2-day meeting dedicated to informing, educating, and fostering the exchange of clinically relevant information in the field of cutaneous malignancies. Following are highlights of presentations from the meeting. [ Read More ]

WCMC 2014

PMO Live: A Global Biomarkers Consortium Initiative

The Third Annual PMO Live Conference, a Global Biomarkers Consortium Initiative, took place in San Francisco, California, on October 31 – November 1, 2014. PMO Live is the only global meeting dedicated to advancing the understanding of value and clinical impact of biomarker research in oncology. Following are highlights of [ Read More ]

PMO Live 2014

Personalized Medicine’s Progress

On November 12, 2014, the Personalized Medicine Coalition (PMC) celebrated its 10th anniversary at the 10th Annual Personalized Medicine Conference at the Harvard Medical School. The occasion gave us a chance to review the progress of personalized medicine and to reflect on the continuing challenges facing the field. Personalized medicine [ Read More ]

Edward Abrahams, PhD

The Last Word